We are formally terminating our equity research coverage of Basilea Pharmaceutica AG. Investors should not rely on any of our previous published research reports or forecasts for Basilea Pharmaceutica AG.
30 Jun 2021
Basilea Pharmaceutica AG: Termination of Coverage
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Basilea Pharmaceutica AG: Termination of Coverage
Basilea Pharmaceutica AG (BSLN:SWX) | 0 0 0.0%
- Published:
30 Jun 2021 -
Author:
Chris Redhead -
Pages:
5
We are formally terminating our equity research coverage of Basilea Pharmaceutica AG. Investors should not rely on any of our previous published research reports or forecasts for Basilea Pharmaceutica AG.